A detailed history of Rmb Capital Management, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Rmb Capital Management, LLC holds 24,468 shares of EXAS stock, worth $1.51 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
24,468
Previous 23,714 3.18%
Holding current value
$1.51 Million
Previous $1 Million 66.43%
% of portfolio
0.04%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$42.43 - $70.83 $31,992 - $53,405
754 Added 3.18%
24,468 $1.67 Million
Q2 2024

Aug 13, 2024

BUY
$41.33 - $74.26 $120,394 - $216,319
2,913 Added 14.0%
23,714 $1 Million
Q1 2024

May 14, 2024

BUY
$56.27 - $73.77 $112 - $147
2 Added 0.01%
20,801 $1.44 Million
Q4 2023

Feb 14, 2024

SELL
$59.06 - $75.72 $649 - $832
-11 Reduced 0.05%
20,799 $1.54 Million
Q3 2023

Nov 13, 2023

SELL
$65.94 - $99.04 $55,125 - $82,797
-836 Reduced 3.86%
20,810 $1.42 Million
Q2 2023

Aug 11, 2023

BUY
$62.68 - $95.05 $2,193 - $3,326
35 Added 0.16%
21,646 $2.03 Million
Q1 2023

May 11, 2023

BUY
$47.19 - $70.77 $28,030 - $42,037
594 Added 2.83%
21,611 $1.47 Million
Q4 2022

Feb 14, 2023

SELL
$30.35 - $53.15 $200,583 - $351,268
-6,609 Reduced 23.92%
21,017 $1.04 Million
Q3 2022

Nov 14, 2022

SELL
$31.97 - $49.37 $351 - $543
-11 Reduced 0.04%
27,626 $898,000
Q2 2022

Aug 01, 2022

SELL
$35.61 - $76.23 $412,506 - $883,048
-11,584 Reduced 29.54%
27,637 $1.09 Million
Q1 2022

May 06, 2022

SELL
$57.56 - $82.54 $2.74 Million - $3.93 Million
-47,621 Closed
0 $0
Q4 2021

Jan 26, 2022

SELL
$72.5 - $100.68 $244,905 - $340,097
-3,378 Reduced 6.62%
47,621 $3.71 Million
Q3 2021

Oct 20, 2021

SELL
$90.24 - $124.05 $11,280 - $15,506
-125 Reduced 0.24%
50,999 $4.87 Million
Q2 2021

Aug 13, 2021

SELL
$93.66 - $139.27 $76,520 - $113,783
-817 Reduced 1.57%
51,124 $6.36 Million
Q1 2021

May 12, 2021

BUY
$116.57 - $155.01 $6.05 Million - $8.05 Million
51,941 New
51,941 $6.85 Million
Q4 2020

Feb 11, 2021

SELL
$99.61 - $142.12 $5.33 Million - $7.61 Million
-53,525 Closed
0 $0
Q3 2020

Nov 10, 2020

BUY
$72.92 - $102.01 $180,112 - $251,964
2,470 Added 4.84%
53,525 $5.46 Million
Q2 2020

Aug 05, 2020

BUY
$55.75 - $92.75 $2.85 Million - $4.74 Million
51,055 New
51,055 $4.44 Million
Q1 2020

May 11, 2020

SELL
$37.9 - $104.44 $1.09 Million - $3.02 Million
-28,880 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$77.66 - $99.74 $543 - $698
-7 Reduced 0.02%
28,880 $2.67 Million
Q3 2019

Nov 12, 2019

SELL
$90.37 - $122.49 $196,554 - $266,415
-2,175 Reduced 7.0%
28,887 $2.61 Million
Q2 2019

Aug 13, 2019

BUY
$89.51 - $118.04 $2.78 Million - $3.67 Million
31,062 New
31,062 $3.67 Million
Q1 2019

May 15, 2019

BUY
$61.98 - $96.5 $21,693 - $33,775
350 Added 1.14%
31,062 $2.69 Million
Q4 2018

Feb 13, 2019

BUY
$56.04 - $82.66 $800,811 - $1.18 Million
14,290 Added 87.02%
30,712 $1.94 Million
Q3 2018

Nov 14, 2018

SELL
$48.29 - $80.6 $764,044 - $1.28 Million
-15,822 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$37.84 - $69.96 $48,321 - $89,338
1,277 Added 8.78%
15,822 $0
Q1 2018

May 14, 2018

BUY
$39.82 - $57.53 $35,041 - $50,626
880 Added 6.44%
14,545 $587,000
Q4 2017

Feb 14, 2018

BUY
$46.49 - $60.51 $635,285 - $826,869
13,665
13,665 $718,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Rmb Capital Management, LLC Portfolio

Follow Rmb Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rmb Capital Management, LLC with notifications on news.